Cancer Epidemiology, Biomarkers & Prevention

Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology. Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in cancer etiology and prevention. It is published by the American Association for Cancer Research and co-sponsored by the American Society of Preventive Oncology.

Cancer Epidemiology, Biomarkers & Prevention
DisciplineCancer epidemiology
LanguageEnglish
Edited byTimothy R. Rebbeck
Publication details
History1991-present
Publisher
Frequencymonthly[1]
4.125 (2014)
Standard abbreviations
ISO 4Cancer Epidemiol. Biomark. Prev.
NLMCancer Epidemiol Biomarkers Prev
Indexing
CODENCEBPE4
ISSN1055-9965 (print)
1538-7755 (web)
OCLC no.23441645
Links

Indexed by ISI Cancer Epidemiology, Biomarkers & Prevention collected an impact factor of 4.125 as reported in the 2014 Journal Citation Reports by Thomson Reuters, ranking it 53 out of 211 journals in the category Oncology[2] and ranking it 17 out of 162 journals in the category Public, environmental & occupational health.[3]

References
  1. Reuters Master Journal List accessed Dec 03, 2009
  2. "Journals Ranked by Impact: Oncology". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.
  3. "Journals Ranked by Impact: Public, environmental & occupational health". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.